Share on LinkedInShare on LinkedIn

ARTICLE · 30 JULY 2013

Four Tips From Merck’s $180M Patent Damages Win Against Apotex

McCarthy Tétrault
McCarthy Tétrault
Contributor
McCarthy Tétrault

McCarthy Tétrault

McCarthy Tétrault LLP provides a broad range of legal services, delivering strategic and...

View firm profile
Explore more from McCarthy Tétrault

In Canadian patent litigation, bifurcation of liability and damages is common.

CanadaIntellectual Property

It is said that the wheels of justice turn slowly, but grind exceedingly fine.  That phrase could certainly apply to Merck's recent win over Apotex in a damages trial for patent infringement in Canada, in a case that started in 1997.

The liability decision finding Apotex guilty of infringement was released in December 2010.  To view the Lexpert write-up of the liability decision click here.  It took another two years before we arrived at the damages trial.  It commenced on April 8, 2013 in Toronto.  On July 16, 2013, the public damages judgment was released.  Merck was awarded damages and interest totalling more than $180 million.  To view the Lexology write-up of the damages decision click here.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from